期刊论文详细信息
BMC Biotechnology
An engineered food-grade Lactococcus lactis strain for production and delivery of heat-labile enterotoxin B subunit to mucosal sites
Research Article
Yuanlin Xi1  Qingtang Fan1  Chen Wang1  Shuaiyin Chen1  Xiaoyan Peng1  Guangcai Duan2  Rongguang Zhang2  Nan Sun2 
[1] Department of Epidemiology and Statistics, College of Public Health, Zhengzhou University, 450001, Zhengzhou, China;Department of Epidemiology and Statistics, College of Public Health, Zhengzhou University, 450001, Zhengzhou, China;Henan Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University, 453003, Xinxiang, China;
关键词: Helicobactor pylori;    Lactococcus lactis;    Lpp20;    Food-grade;    Oral vaccine;    LTB;   
DOI  :  10.1186/s12896-017-0345-6
 received in 2016-08-18, accepted in 2017-03-01,  发布年份 2017
来源: Springer
PDF
【 摘 要 】

BackgroundRecent researches have been focusing on mucosal immune adjuvants, which play the key roles in mucosal immunization and have become the limitation for non-injected vaccine development. Escherichia coli heat-labile enterotoxin B subunit (LTB) was regarded as a promising mucosal adjuvant for its nontoxicity and potent activity. LTB preparation issues have always been recurring, in part owing to that the recombinant LTB expressed by E. coli does not act as its native form.ResultsWe constructed an engineered Lactococcus lactis strain using a food-grade expression system. The LTB secreted by the engineered strain was detected in the culture supernatant, constituting 10.3% of the supernatant proteins, and recognized by mouse anti-LTB antibodies. The engineered strain, co-administered orally to SPF BALB/c mice with a H. pylori vaccine candidate expressing Lpp20 antigen, could significantly enhance the Lpp20-induced mucosal SIgA antibody responses against H. pylori.ConclusionsThis is the first report that LTB was efficiently produced and delivered via using a food-grade lactococcal expression system, which offers a novel production and utilization mode of this crucial mucosal adjuvant. The engineered L. lactis strain secreting LTB has considerable potential for oral vaccine formulation owing to its outstanding safety, adjuvant activity and high-level production.

【 授权许可】

CC BY   
© The Author(s). 2017

【 预 览 】
附件列表
Files Size Format View
RO202311095225458ZK.pdf 2175KB PDF download
12896_2017_345_Article_IEq1.gif 1KB Image download
【 图 表 】

12896_2017_345_Article_IEq1.gif

【 参考文献 】
  • [1]
  • [2]
  • [3]
  • [4]
  • [5]
  • [6]
  • [7]
  • [8]
  • [9]
  • [10]
  • [11]
  • [12]
  • [13]
  • [14]
  • [15]
  • [16]
  • [17]
  • [18]
  • [19]
  • [20]
  • [21]
  • [22]
  文献评价指标  
  下载次数:69次 浏览次数:0次